PPARG and lung carcinoma: In this article,we will review recent data, both from basic sciences experiments and fromclinical studies indicating that activation of the nuclear receptor peroxisomeproliferator-activated receptor γ (PPARγ) may represent a novel strategy for thetreatment and prevention of lung cancer.